Allergy and Infectious Diseases Research obligations in Washington
USAspending.gov records $3,362,694,848.29 in Allergy and Infectious Diseases Research obligations (CFDA 93.855) with place of performance in Washington, across 547 awards. Dividing that total by 547 yields about $6.15 million per award. This page is the 93.855 × WA join, not a ranking of Seattle laboratories and not a claim that every infectious-disease dollar in the state sits under this CFDA. Obligations are commitments, not outlays.
Key figures
- CFDA 93.855 shows $3,362,694,848.29 in Washington obligations on 547 awards.
- Mean obligation is about $6.15 million per award.
- WA is Washington State, not the District of Columbia.
- The cell is program 93.855 × state WA, not all health research in the state.
- Figures are USAspending obligations, not outlays.
The research catalog in Washington State
CFDA 93.855 (ALLERGY AND INFECTIOUS DISEASES RESEARCH) plus Washington place of performance produces $3,362,694,848.29 on 547 awards. The national program table is unfiltered by state. The Washington spending table is unfiltered by CFDA. Only the overlap belongs on this tie.
Five hundred forty-seven awards is a substantial instrument count for a research catalog. Dollars still sit in the billions because the mean obligation is high. The join does not split Seattle from Spokane and does not name institutes. Packet facts are the dollar total, award count, state WA, and CFDA 93.855.
Readers sometimes treat a large CFDA–state total as if it were a budget line the state legislature passed. $3,362,694,848.29 is not that. It is the USAspending obligation sum on awards tagged 93.855 and WA. The overlay table at the program-in-state path is the same cell rendered as a page; this narrative is the join explained in prose. Nothing here ranks Washington against other states on need, performance, or politics.
WA is Washington State. A $3,362,694,848.29 research cell on 547 awards is not a D.C. total and not a Seattle-only map. The about $6.15 million mean sits in research-grant territory. Institute names and fiscal years are not in the facts.
Keeping 93.855 from swallowing other HHS lines
Cancer, aging, and other research catalogs use different CFDA numbers. Housing Choice Vouchers and Coronavirus Relief Fund, which also appear as Washington ties elsewhere, are different catalogs entirely. Adding any of them to $3,362,694,848.29 would invent a total this cell does not contain.
Available facts stop at $3,362,694,848.29, 547 awards, WA, and 93.855. Fiscal years, grant mechanisms, and recipient names are absent. The title is the catalog name, not a disease-prevalence statistic.
The only numeric facts on this packet are $3,362,694,848.29, 547 awards, CFDA 93.855, program title Allergy And Infectious Diseases Research, and geography WA/Washington. Any other dollar, year, recipient, or percentage would be invented. Trivial arithmetic from those facts is allowed: 547 awards into $3,362,694,848.29 is about $6.15 million per award. That quotient is a mean of records, not a typical household, student, or lab.
Washington State’s other large catalogs in this slice include vouchers, CRF, and transit capital. Adding them to $3,362,694,848.29 would invent a state total. This tie is 93.855 × WA only.
Washington as a geography tag
WA is the USAspending place-of-performance code for Washington State, not Washington, D.C. Awards billed to Seattle, Tacoma, or other in-state sites can share the tag. Awards coded to Oregon or Idaho stay outside $3,362,694,848.29 even when investigators collaborate.
Washington federal spending is the all-program parent. CFDA 93.855 is one row on the Washington programs list. $3.36 billion is not the state’s full federal footprint.
Place of performance WA is a two-letter code in the award file. It can mark a state capital, a campus, a housing authority, a transit agency, or a default statewide tag. It does not prove where every subcontract ran, and it does not convert $3,362,694,848.29 into a county map. Awards with a different state code are outside this cell even if people, patients, or riders cross the border.
Mean obligation near $6.15 million
$3,362,694,848.29 ÷ 547 is about $6.15 million per award. That average is pulled by large research instruments; it is not a median R01 and not a typical trainee stipend. The aggregate reports net obligations. Without a transaction table, 547 is best read as award records in the aggregate, not 547 completed studies.
Treat 547 as a record count in an aggregate, not as 547 finished projects. USAspending obligations can be positive new awards or net of downward modifications; the $3,362,694,848.29 figure is the net total supplied in the facts. Without a transaction register on this page, you cannot see how many of the 547 rows are continuations, renewals, or corrections.
Using the Allergy And Infectious Diseases Research–Washington overlay
The overlay target for this tie is the Washington × CFDA 93.855 table. Open that path when you want the same $3,362,694,848.29 / 547-award cell in the site’s data chrome. The national program page for CFDA 93.855 drops the Washington filter. The Washington spending hub drops the CFDA filter. The Washington programs index lists other catalogs beside Allergy And Infectious Diseases Research. All spending ties is the directory of other pairs.
This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that Washington “won” or “lost” federal money, that donations paid for the awards, or that obligations equal cash. Correlation is not causation. The headline number remains $3,362,694,848.29 on 547 awards, from USAspending.gov, for Allergy And Infectious Diseases Research in Washington.
Limits
A large 93.855 total in Washington does not mean state taxpayers chose the awards, and it does not equal outlays. FEC donation files are a different dataset. Correlation is not causation.
Follow Allergy And Infectious Diseases Research in Washington, CFDA 93.855, Washington federal spending, Washington programs, and All spending ties.
Questions
- How much CFDA 93.855 funding is obligated in Washington?
- USAspending records $3,362,694,848.29 in Allergy and Infectious Diseases Research obligations with Washington place of performance across 547 awards. That is the pair total, not the national program total and not an outlay.
- Is this Washington, D.C.?
- No. The state code is WA (Washington State). The $3,362,694,848.29 figure is the 93.855 × WA cell. District of Columbia spending uses a different geography tag.
- Is this all federal health research in Washington?
- No. Other research catalogs use other CFDA numbers. This page is 93.855 only.
- What is the average award?
- About $6.15 million ($3,362,694,848.29 ÷ 547). The mean is not a median and not a typical lab invoice.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.